JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
HCR
4626
PUT
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $135K | ﹤0.01% |
50,700
| – | – |
2019 Q1
1 quarter
|
|
4627
WisdomTree US AI Enhanced Value Fund
AIVL
$412M
| $134K | ﹤0.01% |
1,580
-1,005
| -39% | -$85.4K |
2014 Q4
18 quarters
|
|
4628
Colliers International
CIGI
$4.55B
| $134K | ﹤0.01% |
+1,900
| New | +$125K |
2019 Q2
0 quarters
|
|
|
CIVI
4629
DELISTED
Civitas Resources
CIVI
| $133K | ﹤0.01% |
6,591
+1,992
| +43% | +$43.5K |
2017 Q2
8 quarters
|
|
4630
Ducommun
DCO
$2.61B
| $133K | ﹤0.01% |
2,948
-1,527
| -34% | -$68.5K |
2017 Q4
6 quarters
|
|
|
OPPE
4631
WisdomTree European Opportunities Fund
OPPE
$287M
| $133K | ﹤0.01% |
4,433
| – | – |
2017 Q4
6 quarters
|
|
4632
Fidelity MSCI Information Technology Index ETF
FTEC
$22.7B
| $133K | ﹤0.01% |
2,145
-1,061
| -33% | -$64.7K |
2015 Q4
14 quarters
|
|
4633
Corbus Pharmaceuticals
CRBP
$113M
| $132K | ﹤0.01% |
642
+100
| +18% | +$21.4K |
2017 Q4
6 quarters
|
|
|
CBAY
4634
DELISTED
Cymabay Therapeutics
CBAY
| $132K | ﹤0.01% |
18,920
-277,583
| -94% | -$3.14M |
2018 Q1
5 quarters
|
|
4635
Merchants Bancorp
MBIN
$2.28B
| $131K | ﹤0.01% |
11,624
+5,627
| +94% | +$77.1K |
2017 Q4
6 quarters
|
|
|
USX
4636
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $131K | ﹤0.01% |
26,054
-196,423
| -88% | -$1.2M |
2018 Q2
4 quarters
|
|
|
AGFS
4637
DELISTED
AgroFresh Solutions Inc
AGFS
| $131K | ﹤0.01% |
89,479
+81,785
| +1,063% | +$214K |
2017 Q4
6 quarters
|
|
|
AXJL
4638
DELISTED
WisdomTree Asia-Pacific ex-Japan Fund
AXJL
| $131K | ﹤0.01% |
1,912
-100
| -5% | -$6.7K |
2018 Q2
4 quarters
|
|
|
TCFC
4639
DELISTED
The Community Financial Corporation Common Stock
TCFC
| $130K | ﹤0.01% |
3,940
+1,565
| +66% | +$47.9K |
2017 Q4
6 quarters
|
|
4640
Ovid Therapeutics
OVID
$457M
| $129K | ﹤0.01% |
70,226
-23,865
| -25% | -$42.6K |
2017 Q4
6 quarters
|
|
|
ONDK
4641
DELISTED
On Deck Capital, Inc.
ONDK
| $129K | ﹤0.01% |
31,461
+5,800
| +23% | +$27.4K |
2016 Q4
10 quarters
|
|
4642
Arcturus Therapeutics
ARCT
$417M
| $128K | ﹤0.01% |
+13,245
| New | +$97.2K |
2019 Q2
0 quarters
|
|
4643
Rocket Pharmaceuticals
RCKT
$287M
| $128K | ﹤0.01% |
8,168
+2,404
| +42% | +$42K |
2018 Q2
4 quarters
|
|
4644
Repay Holdings
RPAY
$323M
| $128K | ﹤0.01% |
+12,300
| New | +$127K |
2019 Q2
0 quarters
|
|
4645
CALL
BioCryst Pharmaceuticals
BCRX
$2.07B
| $127K | ﹤0.01% |
+35,000
| New | +$211K |
2019 Q2
0 quarters
|
|
4646
Napco Security Technologies
NSSC
$1.3B
| $127K | ﹤0.01% |
8,752
+242
| +3% | +$3.21K |
2017 Q4
6 quarters
|
|
4647
Schwab US Large-Cap Growth ETF
SCHG
$65.3B
| $127K | ﹤0.01% |
12,248
+7,504
| +158% | +$76.3K |
2018 Q4
2 quarters
|
|
4648
Chunghwa Telecom
CHT
$35.8B
| $126K | ﹤0.01% |
3,444
-9,524
| -73% | -$341K |
2018 Q2
4 quarters
|
|
4649
China Yuchai International
CYD
$1.2B
| $126K | ﹤0.01% |
+8,869
| New | +$137K |
2019 Q2
0 quarters
|
|
4650
Gossamer Bio
GOSS
$65.1M
| $126K | ﹤0.01% |
75
+35
| +88% | +$53.6K |
2019 Q1
1 quarter
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.